Patent · US Active

Dispenser for progestin used for acute and maintenance treatment of DUB

US7556150B2 · kind B2 · utility

2Cited by
32References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 2005
Grant dateJul 7, 2009
Priority date
Expiry dateJul 4, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A dispenser including a first dispensing portion including one group of storage units for each of ten to twenty-eight days, and a second dispensing portion, including at least one storage unit for each of seventeen to thirty days. In the first dispensing portion, a first set includes a group of four storage units for each day, a second set includes a group of three storage units for each day, and a third set includes a group of two storage units for each day. The first dispensing portion contain a progestin. In the second dispensing portion, the first fourteen storage units contain a placebo and the remaining storage units contain a progestin. First and second dispensing portions may be provided as separate dispensing packs, or as a multi-pack of second dispensing portions. The dispenser is useful for treatment of acute episodes of dysfunctional uterine bleeding (DUB) and maintenance treatment for preventing future episodes of DUB.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.